氨溴索雾化吸入在老年慢性支气管炎急性患者中的研究  

Study of Ambroxol Inhalation in Elderly Patients With Chronic Bronchitis

作　　者：刘泉[1] LIU Quan(Department of Pulmonary Disease, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan Hubei 430074, Chin)

机构地区：[1]湖北省中医院肺病科,湖北武汉430074

出　　处：《中国继续医学教育》2018年第14期130-132,共3页China Continuing Medical Education

摘　　要：目的探讨氨溴索雾化吸入在老年慢性支气管炎急性发作患者中的疗效。方法选取2016年1—12月到医院接受治疗的老年慢性支气管炎急性发作患者116例作为研究对象,随机数字法分为对照组(n=58)和观察组(n=58)。对照组采用对症支持治疗,观察组在对照组基础上联合氨溴索雾化吸入治疗。结果观察组治疗后咳嗽或咳痰消失时间、肺部体征改善时间、气促消失时间及喘息消失时间,均短于对照组(P<0.05);两组连续治疗7 d后药物不良反应发生率比较差异无统计学意义(P>0.05)。结论在对症支持治疗基础上联合氨溴索雾化吸入治疗老年慢性支气管炎急性发作患者效果理想。Objective To investigate the curative effect of ambroxol inhalation on the patients with acute attack of chronic bronchitis. Methods From January to December 2016, 116 patients with acute attack of chronic bronchitis treated in hospital were selected as the subjects, and randomly divided into the control group （n=58） and the observation group （n=58）. The control group was treated with symptomatic supportive treatment, while the observation group was treated with aerosol inhalation of ambroxol on the basis of the control group. Results The time of disappearance of cough or expectoration, the improvement of lung signs, the time of disappearance of breath and the time of disappearance of wheeze were shorter in the observation group than in the control group （P 〈 0.05）. There was no signifcant diference in the incidence of adverse drug reactions between the two groups after continuous treatment for 7 d （P 〉 0.05）. Conclusion On the basis of symptomatic support therapy, ambroxol inhalation is efective in the treatment of elderly patients with acute attack of chronic bronchitis.

关 键 词：氨溴索雾化吸入 老年慢性支气管炎 急性发作 

分 类 号：R453[医药卫生—治疗学]